These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7945740)

  • 21. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E; Garcia-Garcia M; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
    Vorbach EU; Arnoldt KH; Hübner WD
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF; Fellerer K; Fichte K; Fischer G; Geyer N; Meya U; Sastre-y-Hernández M; Schöny W; Schratzer M; Soukop W
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A double-blind comparison between mianserin and imipramine (author's transl)].
    Pull CB; Pichot P; Dreyfus JF
    Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antidepressant medication on sexual function: a controlled study.
    Harrison WM; Rabkin JG; Ehrhardt AA; Stewart JW; McGrath PJ; Ross D; Quitkin FM
    J Clin Psychopharmacol; 1986 Jun; 6(3):144-9. PubMed ID: 3711364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind multicentre trial comparing mianserin with imipramine.
    Pichot P; Dreyfus JF; Pull C
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):87S-90S. PubMed ID: 341950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramine.
    Strober M; Freeman R; Rigali J
    Psychopharmacol Bull; 1990; 26(1):80-4. PubMed ID: 2196630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder.
    Bakish D; Lapierre YD; Weinstein R; Klein J; Wiens A; Jones B; Horn E; Browne M; Bourget D; Blanchard A
    J Clin Psychopharmacol; 1993 Dec; 13(6):409-14. PubMed ID: 8120154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipramine blood levels and clinical outcome.
    Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA; Wróbel A; Dudek D; Zieba A
    Pol J Pharmacol; 2004; 56(6):849-55. PubMed ID: 15662100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.